Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.50

€2.50

-3.970%
-0.42
-3.970%
€4.00

€4.00

 
06.05.21 / Tradegate WKN: A0JMYA / Symbol: ZIOP / Name: ZIOPHARM Oncolgy / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€5.00
03.05.21
buy
€3.00
28.11.20
buy
-
02.11.20
Your prediction

Ziopharm Oncology Stock

Heavy losses for Ziopharm Oncology today as the stock fell by -€0.420 (-3.970%).
With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Ziopharm Oncology.
As a result the target price of €4.00 shows a very positive potential of 60.000% compared to the current price of €2.50 for Ziopharm Oncology.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Ziopharm Oncology stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Ziopharm Oncology in the next few years

Pros
1
Could be worthwhile Investment >10% per year
Cons
0
-

Performance of Ziopharm Oncology vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Ziopharm Oncology -3.970% -11.972% -13.194% 0.000% 17.925% -34.211% -65.398%
Kezar Life Sciences 7.040% -2.146% -8.800% -20.000% 15.152% - -
Flexion Therapeutics Inc. -4.000% -8.209% -10.219% -30.114% -31.285% - -
Aravive, Inc. -4.740% -7.339% -12.174% -62.936% -24.486% - -

Other discussions about Ziopharm Oncology Stock

New thread Forum